Drug Testing Locations - Bridgman, MI

Drug Testing in Bridgman, MI

Bridgman, Michigan Statistics

Bridgman, MI, experienced an 18% increase in drug-related arrests in Berrien County over the past two years.

Berrien County, home to Bridgman, MI, reported 240 drug overdose cases in 2022.

The opioid crisis in Bridgman, MI, continues to be a concern, with Berrien County recording a 7% rise in opioid-related incidents.

Bridgman, MI, saw a marked increase in methamphetamine use reported in rehabilitation centers in Berrien County.

Berrien County recorded a decrease in youth drug abuse rates, dropping by 5% in Bridgman, MI, schools in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Bridgman, MI & Drug Testing Policies

In Bridgman, MI, several employers have implemented strict drug testing policies to ensure a safe working environment. Many companies conduct pre-employment drug screenings as a standard practice. Employers emphasize the importance of a drug-free workplace for safety and productivity reasons.

Local businesses often refer to the guidelines set by the Occupational Safety and Health Administration (OSHA) to ensure compliance with federal safety regulations. Additionally, regular random drug tests are conducted among employees to deter drug use.

Industry-specific policies may vary, but larger corporations with operations in Bridgman, MI, often have dedicated employee assistance programs to support workers facing substance abuse challenges. This approach aims to foster a supportive community within the workplace.

Government Efforts with Drug Problems in Bridgman, MI

The government of Bridgman, MI, along with Berrien County, has implemented several initiatives to combat drug abuse. The local government collaborates with Michigan Department of Health and Human Services to increase access to treatment and recovery resources. Educational workshops in schools are organized to raise awareness among the youth.

At the state level, the State of Michigan Opioid Initiative provides crucial funding and strategies aimed at curbing the opioid epidemic impacting Bridgman and surrounding areas. These efforts focus on prevention, treatment, and support for drug overdose survivors.

Local Drug Busts & News in Bridgman, MI

Bridgman, MI, has witnessed several notable drug-related events. In recent years, the Berrien County Sheriff conducted a significant drug bust resulting in the confiscation of large quantities of illegal substances. Such operations are critical in reducing the availability of drugs in the community.

The community frequently collaborates with local law enforcement agencies during drug take-back events to safely dispose of unused or expired medication. These initiatives are part of ongoing efforts to reduce the risk of drug misuse and prevent substance abuse.

Community forums on drug abuse and addiction are held periodically to engage Bridgman residents, providing a platform for sharing information and connecting individuals with necessary resources and support services.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Bridgman, MI. Trusted by employers nationwide for accurate results and exceptional service.

Michigan DOT/Non DOT Physicals

Michigan Vision Tests

Michigan Audiograms

Michigan Respirator Fit Tests

Michigan Lift Tests

Michigan Background Checks

Clinical Testing Services

TB Testing in MI

Diabetes Testing in MI

Infectious Disease Testing in MI

Sickle Cell Anemia Testing in MI

Women/Men's Health Testing in MI

Resources & Citations

Michigan Department of Health and Human Services

Michigan o-drug Initiative

Occupational Safety and Health Administration (OSHA)

Michigan Department of Licensing and Regulatory Affairs

Southwest Michigan Behavioral Health

211

Michigan State Police

NARCAN® Nasal Spray

Recovery Centers in Michigan

Narcotics Anonymous (NA)

Drug Testing Near Bridgman, MI

Fair Plain, MI

Berrien Springs, MI

Three Oaks, MI

Galien, MI

Saint Joseph, MI

Shoreham, MI

Harbert, MI

Stevensville, MI

Shorewood-Tower Hills-Harbert, MI

New Troy, MI

Baroda, MI

Frequently Asked Questions

Customer Reviews